1 – 10 of 10
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
(
- Contribution to journal › Letter
-
Mark
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
(
- Contribution to journal › Letter
- 2020
-
Mark
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis (ETFAD) : treatment targets and treatable traits in atopic dermatitis
(
- Contribution to journal › Letter
- 2019
-
Mark
European task force on atopic dermatitis position paper : treatment of parental atopic dermatitis during preconception, pregnancy and lactation period
(
- Contribution to journal › Article
- 2018
-
Mark
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
(
- Contribution to journal › Article
- 2017
-
Mark
Topical corticosteroid phobia in atopic dermatitis : International feasibility study of the TOPICOP score
(
- Contribution to journal › Article
- 2014
-
Mark
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)
(
- Contribution to journal › Article
- 2011
-
Mark
Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe.
(
- Contribution to journal › Article